Primate renins (human and monkey) are very similar. We used pure human renin to immunize marmosets (Calfithrirjacchus) and thereby produce a chronic blockade of the renin-angiotensinogen reaction. After a control period of 2 months, five male marmosets, on their usual sodium-poor diet, were immunized against pure human renin by three subcutaneous injections of 30 ,ug each, with complete and then incomplete Freund's adjuvant. Three The inhibition of the renin-angiotensin system at its first and rate-limiting step, the action of renin on angiotensinogen, can be achieved by the use of synthetic renin inhibitors (1) and by immunological tools. Indeed, the early studies on renin inhibition deal with passive or active immunization against renin (2-4). However, interpretation of such results is limited by the fact that renin was not completely purified. Thus, heterologous renin was used for immunization protocol, even though it is now known that renin has a very strong immunological specificity. Finally, only blood pressure was monitored in the earlier experiments, and no plasma renin activity or aldosterone assays were available. The renin antibody titer also could not be directly measured.
12.5-labeled human renin at a dilution of -1:10,000). The antibodies inhibited the enzymatic activity of both marmoset and human renins. At the same time, systolic blood pressure decreased significantly from 125 ± 13 mm Hg to 87 ± 8 mm Hg (mean ± SD; 1 mm Hg = 133 Pa). Plasma renin enzyme activity was undetectable in three animals. Plasma aldosterone decreased significantly. After 14 months with low blood pressure, a normal urinary output, and a normal plasma creatinine, the five marmosets became sick and died within one month. At autopsy an immunological renal disease, characterized by the presence of immunoglobulin and macrophage infiltration colocalized with renin, was found. Granulomatous formations, probably due to Freund's adjuvant, could be seen in the lungs and in the kidney. No immunoglobulin was detectable in extrarenal vessels or in other organs. These experiments demonstrate that, in this primate, a chronic blockade of the renin-angiotensin system can be achieved by active immunization against homologous renin, but this blockade is associated with the development of an autoimmune disease localized in the kidney.
The inhibition of the renin-angiotensin system at its first and rate-limiting step, the action of renin on angiotensinogen, can be achieved by the use of synthetic renin inhibitors (1) and by immunological tools. Indeed, the early studies on renin inhibition deal with passive or active immunization against renin (2) (3) (4) . However, interpretation of such results is limited by the fact that renin was not completely purified. Thus, heterologous renin was used for immunization protocol, even though it is now known that renin has a very strong immunological specificity. Finally, only blood pressure was monitored in the earlier experiments, and no plasma renin activity or aldosterone assays were available. The renin antibody titer also could not be directly measured.
The acute passive immunization of renovascular hypertensive dogs (5) and normotensive marmosets (6) with specific homologous renin antibodies clearly showed that the level of blood pressure depended on renin. From this latter study (6) it was concluded that renin regulated blood pressure in the normotensive marmoset ingesting its usual amount of sodium. The present study was designed to examine the effects of active immunization against renin in marmosets and to observe the effects of chronic blockade of the renin substrate reaction. (8) . Five marmosets were immunized by three repeated subcutaneous injections of 30 Ag of highly purified human renin (specific activity, 680 Goldblatt units per mg of protein). Purification was performed by immunoadsorption on a monoclonal antibody from ajuxtaglomerular cell tumor as described by Galen et al. (9) . The first injections were performed in complete Freund's adjuvant (0.5 ml), the two others in incomplete Freund's adjuvant (0.5 ml). Three control animals received only the adjuvant. Injections were repeated at intervals of 3 weeks.
MATERIALS AND METHODS
In Vitro Experiments. The presence of renin antibodies was determined by the ability of marmoset plasma to bind pure human iodinated renin. The titer was defined as the antiserum dilution able to bind 50% of the renin tracer. Plasma renin concentration was measured by radioimmunoassay (RIA) of angiotensin I generated by 1 hr of incubation of 1:50-diluted marmoset plasma in the presence of an excess (635 pmol/200 gl) of human angiotensinogen (6) . When the plasma renin concentration of the immunized marmoset remained high despite a high titer of renin antibody, the blockade of renin enzymatic activity was tested by incubating undiluted or 1:2-diluted plasma for 1-3 hr at pH 7.5 without addition of exogenous substrate. The ability of marmoset anti-renin serum to inhibit the enzymatic activity of exogenous marmoset and human renin was tested by the incubation of human and control marmoset plasma at 40C for 24 hr with successive dilutions of antirenin immune serum in 0.01 M sodium phosphate buffer, pH 7.5. Human angiotensinogen was then added and incubations were carried out for 1 hr. Plasma angiotensinogen was measured by the RIA of angiotensin I generated by the incubation of a 1:100 dilution of marmoset plasma in the presence of a large excess of human Abbreviations: SBP, systolic blood pressure; PAP, peroxidase-antiperoxidase.
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Morphological Studies. After natural death or sacrifice, a complete postmortem examination was conducted on four of five immunized animals and on one control. Kidneys, aorta, lungs, heart, liver, spleen, inguinal lymph nodes, adrenal glands, testis, brain, and cutaneous fragments were removed for standard histological examination. Kidney was fixed in Duboscq Brazil fixative, other organs in buffered 10% Formalin. Tissues were embedded in paraffin after dehydration and were cut at 5-6 ,um. Kidney sections were stained with Masson's trichrome, hematoxylin/eosin, and methenamine/silver. Immunomorphology was investigated in the organs of each animal as follows. Fixed sections of kidney with paraffin removed were immunostained with polyclonal rabbit antibody to human renin (11) by the peroxidase-antiperoxidase technique (PAP, Kit Biolyon, Lyon, France). Kidney, aorta, and lung samples were snap-frozen in liquid nitrogen. Cryostat sections were cut at 6 ,um from this material and allowed to react with polyclonal rabbit antibody to human renin (11) in indirect immunofluorescence measurements and in direct immunofluorescence measurements with fluoresceinated polyclonal rabbit antibodies to human immunoglobulin, human IgG, human complement component C3, human complement component Clq, and human fibrinogen. Anti-human immunoglobulin is known to cross-react with marmoset immunoglobulins (12) . Slides were examined with a Leitz fluorescence microscope.
Statistical Methods. Results are expressed as mean + SD. One-way analysis of variance was used for comparison of blood pressure, body weight, and plasma parameters of controls and immunized animals.
RESULTS
Effects of Renin Immunization on Blood Pressure and Hormonal Parameters. SBP, followed for a period of 8 weeks before immunization, was stable ( Fig. 1) . After the first administration of complete Freund's adjuvant, a nonspecific fall in blood pressure was observed in immunized and control animals. The SBP subsquently returned to previous values in the controls (127 ± 7 mm Hg before, versus 121 ± 8 mm Hg after injections), but after active immunization there was a significant decrease in SBP from 128 ± 7 mm Hg before to 85 ± 5 mm Hg (P < 0.01). Before immunization, body weights in the experimental animals were similar to those of controls (350 ± 10 g). After immunization, body weight decreased gradually in immunized animals (286 7 g) but not in controls (334 ± 11 g). In the five immunized marmosets, after the third injection, the titer of renin antibodies was greater than or equal to 1:10,000 (Fig. 2) . No binding of 1251I-labeled renin was detected in controls and in preimmune plasma. Plasmas of immunized marmosets blocked exogenously added human and marmoset renin, in parallel dose-response curves (Fig.  3) . In three of five marmosets plasma renin concentration decreased to almost zero after immunization (Fig. 4) . In two others, despite an antibody titer higher than 1:10,000 and despite a significant decrease in blood pressure, there was no significant decrease in plasma renin concentration. However, pooled plasma samples from these marmosets inhibited the renin angiotensinogen reaction; at pH 7.5, with 1:2 to 1:1 plasma dilution, no angiotensin I was generated in 1 or 3 hr (controls: 1.06 ng of angiotensin I per ml in 1 hr and 2.83 ng of angiotensin I per ml in 3 hr).
Plasma angiotensinogen did not change after immunization (3988 + 180 pmol/ml before, versus 3343 ± 194 pmol/ml after and 4046 ± 136 pmol/ml in controls). Plasma aldosterone was 979 ± 161 pg/ml in controls and did not vary with time, but plasma aldosterone of immunized marmosets was 1444 ± 150 pg/ml before immunization and decreased significantly (P < 0.01) to 416 + 44 pg/ml after immunization. Plasma creatinine concentration did not change with time in control marmosets (29 ± 12 AM). In immunized marmosets, plasma creatinine did not increase significantly after immunization (33 ± 12 ,uM before versus 36 ± 17 ,M after immunization). Noticeably, the complete disappearance in PRC was not associated with significant changes in plasma creatinine.
From 2 to 6 months (mean: 25 + 9 weeks) after immunization, the marmosets became sick, with clinical signs of a progressive disease: very low blood pressure (s70 mm Hg) and decrease in hematocrit (<25%) and body weight. Plasma creatinine increased just before death (99 ± 13 AM). In these animals hemoglobin was very low (7 ± 0.5 g/100 ml) and platelet count was higher than in controls (106/mm3 versus 0.6 x 106/mm3). Leukocyte count was low (5 x 103/mm3 in immunized animals versus 7.7 x 103/mm3 in controls), with the following differential: neutrophil polynuclears 70%, lymphocytes 25%, and monocytes 5%. The consumption of complement was measured in serum of one immunized animal, one control animal, and a normal human. There was no abnormal complement consumption in the serum of the immunized marmoset (50% hemolytic unit of complement, CH 50 = 297%) as compared to the control marmoset (CH 50 = 322%) and to the normal human serum (CH 50 = 100%). In the last month oflife, a renal tubulopathy appeared in these animals, associating major diuresis (30 Immunomorphology. Results were homogeneous from one marmoset to another. Immunostaining of fixed kidney sections after removal of paraffin showed hyperplasia of reninpositive cells (which were present) in nearly all juxtaglomerular apparati, extending down the afferent arteriole and often all the way to the intralobular artery; these recruited cells were localized in the external part of the arterial media (Fig.  7) . Immunofluorescence of frozen sections with anti-renin, anti-human immunoglobulin, and anti-human IgG antibodies gave the same patterns of immunostaining, consisting of granular extracellular positive staining in the external part of arteriolar and arterial walls from the juxtaglomerular apparatus to the interlobular arteries (Fig. 8) (6) . Conversely, the absence or insufficiency of interspecies renin homology might explain the failure to obtain a blood pressure lowering or a short-lived hypotensive effect during active immunization (13) (14) (15) (16) (17) (18) when heterologous renin is used (13) (14) (15) (16) (17) (18) . The choice of the normotensive marmoset has several other advantages: on a regular diet (i.e., rich in potassium and poor in sodium), the high plasma renin and aldosterone values indicate a chronic stimulation of the renin-angiotensin-aldosterone system. Indeed, these normotensive animals respond by a significant blood pressure decrease to the passive (6) or active immunization against renin and are a model of choice for testing the acute effect of renin inhibitors (19) . Finally, marmosets are known to be good responders to immunogen, as shown by the production of antibodies to human luteinizing hormonereleasing hormone (20) . In the present study all five marmosets developed high renin antibody titers. This facility to break down the tolerance to a self protein (i.e., renin) could be due to the low amounts of circulating renin (in the order of the fmol/liter) (21) .
The renin antibodies generated in marmosets were able to inhibit in vitro the enzymatic activity of exogenous marmoset and human renin. (19) . The high decrement in SBP observed after anti-renin active immunization could be partly explained by a complete and chronic blockade of the renin enzymatic activity in these animals in which the renin-angiotensin system is especially activated. Because ofthe autoimmune reaction to the renin immunization, it is also possible that some of the lowering of SBP was not specific for the renin blockade but occurred secondary to the diffuse autoimmune disease.
After renin immunization, plasma aldosterone decreased significantly but remained detectable. These results confirm early experiments (22, 23) involving acute immunization against renin in dogs. In marmosets, the blockade of the renin-angiotensinogen reaction inhibited the secondary hyperaldosteronism but preserved the basal rate of aldosterone secretion. In the kidney, renin immunofluorescence staining was increased in immunized animals. These results extend previous studies using a bioassay for renal renin (24, 25) or the granule and immunofluorescence index (26) to evaluate renin production and storage within the kidney. Renin could be localized by immunofluorescence within the myoepithelioid cells of arterioles on fixed kidney sections but also in the interstitial space on sections of frozen kidney. This increase in renal biosynthesis and storage could be due to the removal of the negative feedback of suppressing angiotensin II, as occurs during converting enzyme inhibition.
During the first months after immunization, the animals were healthy as judged by their body weight, alertness, plasma creatinine, and hematocrit. However, 2-6 months later, they rapidly developed a clinical syndrome characterized by a low body weight, hair loss, passivity, a fall in SBP, and increase in plasma creatinine, which could be attributed to a general disease in these animals. This disease observed in immunized animals 2-6 months after the initial immunization was not observed in control animals and could be attributed to an autoimmune disease. In the immunized marmosets granulomatous formation in the lung and in the kidney could probably be attributed to the Freund's complete adjuvant and more specifically to its mycobacteria (27) (28) (29) . In the kidney, however, all the lesions could not be attributed to Freund's adjuvant. The colocalization of renin and immunoglobulin within the interstitial space of the immunized kidney indicated the existence of a kidney autoimmune disease directly related to renin. The characteristic distribution of macrophages around the juxtaglomerular apparatus and the arterioles, and the medial necrosis of some arteriolar walls within the kidney, were also in favor of a specific renin autoimmune disease. Finally, the predominant lesions within the kidney, including the presence of immunoglobulin, the existence of a tubulopathy, and a terminal interstitial nephritis showed that active renin immunization induced a kidneyspecific autoimmune disease. It can be considered unique in that it predominates at the site of renin production and release, within the afferent arterioles, the interlobular arteries, and the renal interstitium.
Similar observations have been made in autoimmune thyroiditis induced by immunization against thyroglobulin (for review see ref. 21 ). In these experimental models of thyroiditis, thyroglobulin antibodies are present in plasma and within the thyroid; the humoral autoimmune reaction is associated with a cellular infiltration of the thyroid, particularly with macrophages (30) . No lesions could be seen in organs other than the thyroid. As in experimental autoimmune thyroiditis, the present renin autoimmune disease was characterized by autoantibodies and cellular infiltration, which were organ specific since no immunoglobulin or specific cellular infiltration in organs other than kidneys was detected. In early studies of active immunization against hog immunization was achieved without the utilization of Freund's adjuvant. This raises the question of the role of Freund's adjuvant in the development of this autoimmune tissue disease.
In summary, active immunization against human renin is thus possible in another primate. Before the appearance of the autoimmune disease, renin immunization lowered blood pressure in normotensive animals, decreased plasma aldosterone, and did not induce acute renal insufficiency. It would be worthwhile to conduct experiments with other immunomodulators or with synthetic renin epitopes (31) to see whether it is possible to chronically block renin activity by active immunization without inducing an autoimmune disease.
